EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Genomic and phenotypic inconsistencies in Pseudomonas aeruginosa resistome among intensive care patients

Mihails Dolgusevs, Nityanand Jain, Oksana Savicka, Reinis Vangravs, Jevgenijs Bodrenko, Edvins Bergmanis, Dace Zemite, Solvita Selderina, Aigars Reinis, Baiba Rozentale

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1335096 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Mihails Dolgusevs und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Doctoral Studies, Riga Stradinš University, Riga, Latvia. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections, Anti-Bacterial Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Pseudomonas aeruginosa , a difficult-to-manage nosocomial pathogen, poses a serious threat to clinical outcomes in intensive care (ICU) patients due to its high antimicrobial resistance (AMR). To promote effective management, it is essential to investigate the genomic and phenotypic differences in AMR expression of the isolates.

Methods

A prospective observational study was conducted from July 2022 to April 2023 at Liepaja Regional Hospital in Latvia. The study included all adult patients who were admitted to the ICU and had a documented infection with P. aeruginosa , as confirmed by standard laboratory microbiological testing and short-read sequencing. Since ResFinder is the only sequencing-based database offering antibacterial susceptibility testing (AST) data for each antibiotic, we conducted a comparison of the resistance profile with the results of phenotypic testing, evaluating if ResFinder met the US Food and Drug Administration (FDA) requirements for approval as a new AMR diagnostic test. Next, to improve precision, AST data from ResFinder was compared with two other databases – AMRFinderPlus and RGI. Additionally, data was gathered from environmental samples to inform the implementation of appropriate infection control measures in real time.

Results

Our cohort consisted of 33 samples from 29 ICU patients and 34 environmental samples. The presence of P. aeruginosa infection was found to be associated with unfavourable clinical outcomes. A third of the patient samples were identified as multi-drug resistant isolates. Apart from resistance against colistin, significant discrepancies were observed when phenotypic data were compared to genotypic data. For example, the aminoglycoside resistance prediction of ResFinder yielded a major errors value of 3.03% for amikacin, which was marginally above the FDA threshold. Among the three positive environmental samples, one sample exhibited multiple AMR genes similar to the patient samples in its cluster.

Conclusion

Our findings underscore the importance of utilizing a combination of diagnostic methods for the identification of resistance mechanisms, clusters, and environmental reservoirs in ICUs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaPseudomonas InfectionsAnti-Bacterial AgentsMicrobial Sensitivity TestsIntensive Care UnitsPhenotypeHumansProspective StudiesFemaleMaleMiddle AgedCross InfectionAgedDrug Resistance, BacterialDrug Resistance, Multiple, BacterialGenomicsLatviaAdultColistinGenome, Bacterial

Stichwörter der Autor:innen

Pseudomonas aeruginosaantimicrobial resistanceantimicrobial susceptibility testingenvironmental reservoirsintensive care unitnext-generation sequencing

Substanzen

Anti-Bacterial AgentsColistin

Autor:innen und Institutionen

  • Department of Doctoral Studies, Riga Stradinš University, Riga, Latvia.
  • Intensive Care Unit, Liepaja Regional Hospital, Liepaja, Latvia.
  • Statistics Unit, Riga Stradinš University, Riga, Latvia.
  • Joint Microbiology Laboratory, Pauls Stradinš Clinical University Hospital, Riga, Latvia.
  • Department of Infectology, Riga Stradinš University, Riga, Latvia.
  • Laboratory "Latvian Centre of Infectious Diseases", National Microbiology Reference Laboratory, Riga, Latvia.

Zitieren

APA

Dolgusevs, M., Jain, N., Savicka, O., Vangravs, R., Bodrenko, J., Bergmanis, E., Zemite, D., Selderina, S., Reinis, A., & Rozentale, B. (2024). Genomic and phenotypic inconsistencies in Pseudomonas aeruginosa resistome among intensive care patients. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1335096

Vancouver

Dolgusevs M, Jain N, Savicka O, Vangravs R, Bodrenko J, Bergmanis E, et al. Genomic and phenotypic inconsistencies in Pseudomonas aeruginosa resistome among intensive care patients. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1335096

BibTeX
@article{Dolgusevs2024,
  author = {Dolgusevs, Mihails and Jain, Nityanand and Savicka, Oksana and Vangravs, Reinis and Bodrenko, Jevgenijs and Bergmanis, Edvins and Zemite, Dace and Selderina, Solvita and Reinis, Aigars and Rozentale, Baiba},
  title = {Genomic and phenotypic inconsistencies in Pseudomonas aeruginosa resistome among intensive care patients},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1335096}
}
Kostenlos starten →